McKesson (MCK) Reaffirms FY19 Guidance, Preliminary Guidance for Q1 Tops Views
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/22/2026
- Wall St indexes advance with boost from chips, Iran optimism
- Intel soars after Trump says Apple agreed to work with chipmaker on US production
- Apple CEO warns price hikes 'unavoidable' as chip costs bite - WSJ
- Wall Street scrambles to lift Micron price targets ahead of earnings
- SanDisk and Micron surge as Apple confirms memory price pass-through
- Zelenskiy: best guarantee of Europe's future is fast-track EU membership for Ukraine
- Needham Starts NeoVolta (NEOV) at Buy
- CoreWeave trains DeepSeek-V3 in two minutes in MLPerf benchmark
- Companies to add 40 million barrels of oil to US SPR after Iran war ends, energy secretary says
- China makes small dent in deflation battle as supply-demand imbalance persists
Cowen Reiterates Outperform on McKesson (MCK) Following Investor Day
June 29, 2018 7:42 AM EDTCowen reiterated an Outperform rating and $174.00 price target on McKesson (NYSE: MCK) following the company's investor day. Management is focused on driving cost savings and emphasized its increased exposure to growth areas, namely manufacturer services, specialty and retail pharmacy.
MCK fell short of... More
McKesson (MCK) PT Lowered to $158 at RBC Capital, Sees Limited Near to Medium Term Impact from Amazon
June 29, 2018 7:39 AM EDTRBC Capital lowered its price target on McKesson (NYSE: MCK) to $158.00 (from $171.00) while maintaining a Sector Perform rating.
Analyst George Hill notes the company's investor day that was largely overshadowed by the entry of Amazon into the pharma supply... More
Amazon to buy PillPack in potentially disruptive drug retail push
June 28, 2018 8:47 AM EDTBy Ankur Banerjee and Bill Berkrot
(Reuters) - Amazon.com Inc said on Thursday it would buy small online pharmacy PillPack, a move that will put the world's biggest online retailer in direct competition with drugstore chains, drug distributors and pharmacy benefit managers.
The deal's potential to disrupt major players across the drug supply chain nationwide prompted a sell-off in shares of possible rivals, while sending Amazon shares up 2.5 percent.
PillPack supplies pre-sorted prescription drugs and other services to people who take multiple medications, a growing market as the U.S. population ages and requires treatment for... More
